Goodwin advised Acorai on the financing round. Acorai announced its $4.5 million oversubscribed series seed financing round. The round was led by Solardis Health Ventures, with...
You must be a Standard 1 Year member to access this content.
Goodwin Procter, Kinstellar and Loyens & Loeff advised Kinnevik on the deal, while Orrick represented Salesforce Ventures. Kinnevik announced its investment into Mews Systems as part of...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Novo Holdings on the deal. Novo Holdings acted as a lead investor in Roslin Tech’s £11 million Series A funding round. Other participating...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Dai on the deal. Dai announced the completion of their $2 million investment round, backed by a crowdfunding campaign with 60% of value coming...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Insempra on the deal. Insempra announced its strategic investment into Solena Materials Ltd (“Solena”) a synthetic biology company. Solena, a spin-out from Imperial College...
You must be a Standard 1 Year member to access this content.
Goodwin advised 2150 on the deal, while Chammas & Marcheteau represented the founders of LEKO LABS. Maples and Calder and Orrick UK acted for LEKO LABS....
You must be a Standard 1 Year member to access this content.
Goodwin advised BIVF, Novo and Evotec on the deal. Boehringer Ingelheim Venture Fund GmbH (“BIVF”), Novo Holdings REPAIR Impact Fund (“Novo”) and Evotec SE (“Evotec”) led...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Morningside on the deal. Morningside announced its lead investment into ieso, as part of a $53m Series B funding round which included investments from...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Closed Loop Medicine Ltd on the deal. Closed Loop Medicine Ltd announced its oversubscribed £13 million financing from a range of top UK and...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Omega Funds on the deal. Artios Pharma Limited (Artios), a leading DNA Damage Response (DDR) company exploiting a broad DDR-based platform and small...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Quanta Dialysis Technologies on the deal, while Latham & Watkins advised Novo Holdings. Quanta Dialysis Technologies announced its completion of a $245 million...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Jeito Capital on the deal. Jeito Capital, a rapidly emerging independent Private Equity firm dedicated to biotech and biopharma, announced that it has led...
You must be a Standard 1 Year member to access this content.
